StockData
Curanex Pharmaceuticals Inc logo

Curanex Pharmaceuticals Inc (CURX) shareholders

CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.70+0.07 (+1.40%)

Close on Nov 17, 2026Market cap $7.37MP/E –Yield –

Ownership

Who owns Curanex Pharmaceuticals's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Jun LiuCEO and President, Director, 10% owner10,524,56033.56%Sep 2, 2025
Huijuan ZhongChief Science Officer, Director––Sep 2, 2025
Ning ZhangChief Technology Officer––Sep 2, 2025
Dian Ying JingSecretary, 10% owner4,651,00014.83%Sep 2, 2025
Liqin XieChief Operating Officer––Sep 2, 2025
Xiaohui HaoDirector––Sep 2, 2025
Yong YanDirector––Sep 2, 2025
Helen Hong HsuDirector––Sep 2, 2025
Chang Liu10% owner7,982,22025.45%Sep 2, 2025

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
0.38%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+14.4%
From 0M shares
Short volume, 20 days
20.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Curanex Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 3,181 shares on Sep 18, 2026 over the last 90 days.

See a number that looks wrong?